Products for Research Use Only
RegisterLogin

Phortress

CAT: 0804-HY-103223-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-103223-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Phortress is a high affinity AhR ligand that elicits antitumor activity by inducing transcription of CYP1A1[1][2].
CAS Number
328087-38-3
Product Name Alternative
NSC 710305
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/phortress.html
Purity
98.19
Solubility
DMSO : 125 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=CC=C(C2=NC3=CC(F)=CC=C3S2)C=C1C)[C@@H](N)CCCCN.[H]Cl.[H]Cl
Molecular Formula
C20H25Cl2FN4OS
Molecular Weight
459.41
Precautions
H302, H315, H319
References & Citations
[1]Bradshaw TD, et al. In vitro evaluation of amino acid prodrugs of novel antitumour 2- (4-amino-3-methylphenyl) benzothiazoles. Br J Cancer. 2002 Apr 22;86 (8) :1348-54.|[2]Bradshaw TD, Westwell AD. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr Med Chem. 2004 Apr;11 (8) :1009-21.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP1

Alternative Products

CatalogName
A8614-50Phortress
DNA08738Phortress dihydrochloride
A18458-25Phortress 25mg
A18458-100Phortress 100mg
A18458-10Phortress 10mg
A18458-50Phortress 50mg
A18458-5Phortress 5mg
T12449-01Phortress free base

Popular Products